ArticleTurkish journal of obstetrics and gynecology2024
Retrospective analysis of the indications, methods, and complications of pregnancy termination.
Article in Turkish journal of obstetrics and gynecology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Determining the 90% Effective Dose of Remimazolam to Prevent Physical Movement in Surgical Abortions: A Biased-Coin Up-and-Down Sequential Allocation Trial.Drug design, development and therapy · 2025Trial
- Navigating Anesthetic Management in the Setting of Uterine Rupture and Spinal Fracture: A Case Report.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the indications and methods of termination of pregnancy (TOP) and to identify maternal complications that occur during TOP. Materials and Methods: This retrospective study was conducted at a single tertiary center with a total of 231 patients who underwent TOP from April 2019 to March 2023. The patients were divided into two groups based on gestational age at the time of TOP and the presence of complications. Group 1 consisted of patients with a gestational age of 11-22+6 weeks (n=196), while Group 2 comprised patients with a gestational age of 23-30 weeks (n=35). Additionally, the patients were categorized based on complications into those with complications (n=63) and those without complications (n=168). The TOP protocol involves misoprostol, a uterine balloon, a combination of misoprostol and balloon, or oxytocin. Procedure-related complications included the following: Rehospitalization, rest placenta, infection, uterine rupture, blood transfusion, and repeated manual vacuum curettage. Results: The median gestational age at TOP was 18.0±3.3 weeks for women without complications and 19.5±5.1 weeks for those with complications, it was 19.5±5.1 weeks (p=0.037). In the group with complications, the combined misoprostol-balloon method was used significantly more frequently, and the rate of previous cesarean sections was higher (p<0.05). The induction time was longer in the oxytocin group (p<0.05). The misoprostol-balloon combination group had the highest rate of uterine rupture (p<0.05). Conclusion: TOP during advanced gestation is associated with increased rates of maternal complications, such as increased transfusion, uterine rupture, and hysterotomy. Higher gestational age and previous uterine surgery are the main causes of TOP-related maternal complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.